Skip to main content
OpenTrials

Clinical trial condition

Cholestasis, Intrahepatic

Explore clinical trials studying Cholestasis, Intrahepatic. Study availability and eligibility vary by location and protocol.

169 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Cholestasis, Intrahepatic trial results

Completed

Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.

NCT03226067

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • University California Davis Sacramento, California, United States
  • Ventura Clinical Trials Ventura, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 61 locations
View Trial Details
Completed

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS)

NCT02047318

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +11 more
Locations
  • Birmingham Children's Hospital Birmingham, West Midlands, United Kingdom
  • Leeds Teaching Hospital NHS Trust Leeds, West Yorkshire, United Kingdom
  • Kings College Hospital London, United Kingdom
View Trial Details
Completed

Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)

NCT02160782

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +11 more
Locations
  • Children's Hospital Westmead Westmead, New South Wales, Australia
  • The Royal Children's Hospital Melbourne Parkville, Victoria, Australia
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Hopital Femme Mere Enfant De Lyon Bron, France
View Trial Details
Completed

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome

NCT02117713

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California at San Francisco Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View Trial Details
Completed

Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)

NCT00570765

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +8 more
Locations
  • Henry Ford Detroit, Michigan, United States
  • Baylor College of Medicine Houston, Texas, United States
  • Virginia Commonwealth University Richmond, Virginia, United States
  • Virginia Mason Medical Center Seattle, Washington, United States
View all 21 locations
View Trial Details
Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

NCT03394924

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Arkansas Diagnostic Center Little Rock, Arkansas, United States
  • Texas Clinical Research Institute Little Rock, Arkansas, United States
  • Southern California Research Center Coronado, California, United States
View all 86 locations
View Trial Details
Completed

Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

NCT01473524

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • UC Davis Medical Center Sacramento, California, United States
  • Scripps Clinic San Diego, California, United States
  • University of Colorado, Denver Aurora, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
View all 59 locations
View Trial Details
Completed

Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis

NCT02966834

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +13 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Novi, Michigan, United States
View all 66 locations
View Trial Details

Related conditions